1. Home
  2. COEP vs WYY Comparison

COEP vs WYY Comparison

Compare COEP & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • WYY
  • Stock Information
  • Founded
  • COEP 2017
  • WYY 1991
  • Country
  • COEP United States
  • WYY United States
  • Employees
  • COEP N/A
  • WYY N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • WYY EDP Services
  • Sector
  • COEP Health Care
  • WYY Technology
  • Exchange
  • COEP Nasdaq
  • WYY Nasdaq
  • Market Cap
  • COEP 27.4M
  • WYY 33.6M
  • IPO Year
  • COEP N/A
  • WYY 1998
  • Fundamental
  • Price
  • COEP $10.77
  • WYY $2.91
  • Analyst Decision
  • COEP
  • WYY Strong Buy
  • Analyst Count
  • COEP 0
  • WYY 1
  • Target Price
  • COEP N/A
  • WYY $7.00
  • AVG Volume (30 Days)
  • COEP 56.9K
  • WYY 62.3K
  • Earning Date
  • COEP 08-15-2025
  • WYY 08-14-2025
  • Dividend Yield
  • COEP N/A
  • WYY N/A
  • EPS Growth
  • COEP N/A
  • WYY N/A
  • EPS
  • COEP N/A
  • WYY N/A
  • Revenue
  • COEP $62,874.00
  • WYY $142,582,209.00
  • Revenue This Year
  • COEP N/A
  • WYY $9.05
  • Revenue Next Year
  • COEP N/A
  • WYY $12.24
  • P/E Ratio
  • COEP N/A
  • WYY N/A
  • Revenue Growth
  • COEP N/A
  • WYY 24.03
  • 52 Week Low
  • COEP $2.31
  • WYY $2.19
  • 52 Week High
  • COEP $13.70
  • WYY $6.25
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.53
  • WYY 34.63
  • Support Level
  • COEP $11.30
  • WYY $2.99
  • Resistance Level
  • COEP $12.71
  • WYY $3.23
  • Average True Range (ATR)
  • COEP 0.89
  • WYY 0.18
  • MACD
  • COEP 0.18
  • WYY -0.01
  • Stochastic Oscillator
  • COEP 54.39
  • WYY 1.75

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

Share on Social Networks: